Comparison of FEV1 and mid flow parameters as markers of bronchial hyper responsiveness to methacholine

M. P. Swanney, L. E. Beckert, K. A. Sallaway, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America)

Source: Annual Congress 2003 - Respiratory structure & function: clinical
Session: Respiratory structure & function: clinical
Session type: Thematic Poster Session
Number: 1798
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, K. A. Sallaway, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). Comparison of FEV1 and mid flow parameters as markers of bronchial hyper responsiveness to methacholine. Eur Respir J 2003; 22: Suppl. 45, 1798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The accuracy of mid expiratory flow and dysanapsis parameters for evaluation of methacholine provocation test
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009


Effects of inhaled histamine and methacholine on the lung function parameters obtained by spirometry and forced oscillations in asthmatic children
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010


Relationships between bronchial obstruction and differential NO parameters after methacholine challenge testing
Source: Annual Congress 2011 - Lung and airway function
Year: 2011

Comparison of variations of FEV1 and forced oscillation technique during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 339s
Year: 2004

Comparison of bronchodilatator response of FEV1 and airway resistance
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


Post-bronchodilator changes in volumes and airway caliber according to Peak flow and FEV1 reversibility
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019

Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Assessment of airway responsiveness: Comparison of forced spirometry and body plethysmography for methacholine challenge tests
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010

Comparison of FEV1 and specific airway conductance in assessing bronchial response to occupational agents
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003

sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003

How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
Source: Eur Respir J 2009; 33: 1396-1402
Year: 2009



Can the interrupter resistance be used to measure airway hyperresponsiveness during the methacholine challenge test as a substitute for FEV1?
Source: Virtual Congress 2021 – New insights into lung function testing
Year: 2021


A comparison of the response to inhaled histamine measured with FEV1 and sGaw in healthy subjects
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


Correlation of biological markers of inflammation in peripheral blood with bronchoprovocative testing with histamine in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 287s
Year: 2004

Analysis of tidal expiratory flow pattern in the assessment of methacholine-induced bronchoconstriction in adult asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 352s
Year: 2001

Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Relationship between pre-bronchodilator FEV1 and ex-vivo intrinsic tone in human small airways
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019

The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004